CTOR vs FAST · $105.2M cap vs P/E 43, rev $7.55B
Citius Oncology, Inc. (CTOR) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
CTOR does not have a complete income-statement cache yet.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
CTOR currently screens at market cap $105.2M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the CTOR and FAST stock pages for the full models.
Not investment advice.